Cite this answer
Kisspeptin-10: quick citable summary
Kisspeptin-10 is listed by PeptaHub as a sexual health peptide with a research only legal-status classification. The page summarizes mechanism, research context, common routes, safety notes, and references for writers and AI answer engines.
PeptaHub. “Kisspeptin-10: Mechanism, Research Context, Safety.” peptahub.com, 2026. https://peptahub.com/peptides/kisspeptin-10. Licensed CC BY 4.0.
License: Creative Commons Attribution 4.0 International. Link back to https://peptahub.com/peptides/kisspeptin-10.
What is Kisspeptin-10?
Kisspeptin-10 is the shortest bioactive kisspeptin fragment and the master upstream regulator of GnRH controlling the reproductive hormone cascade. Clinical studies show it acutely increases LH and testosterone in men and is being investigated for fertility diagnostics.
Overview
Kisspeptin-10 is the shortest bioactive fragment of kisspeptin, a neuropeptide that plays a central role in the initiation of puberty and regulation of the reproductive axis. It is the master upstream regulator of gonadotropin-releasing hormone (GnRH), making it a key switch in the hormonal cascade that controls testosterone, estrogen, LH, and FSH production. It is being studied as a diagnostic tool and therapeutic for reproductive disorders.
Mechanism of action
Kisspeptin-10 binds to the KISS1R (GPR54) receptor on GnRH neurons in the hypothalamus, triggering the release of GnRH. This initiates the hypothalamic-pituitary-gonadal (HPG) axis cascade: GnRH stimulates LH and FSH release from the pituitary, which in turn stimulates testosterone/estrogen production in the gonads. Kisspeptin acts as the 'master switch' of this entire system — without kisspeptin signaling, puberty does not occur.
Reported study ranges
| Purpose | Route | Reported range | Frequency | Notes |
|---|---|---|---|---|
| hormonal optimization / LH stimulation | subcutaneous | 100–500 mcg | 1-2x daily | Limited community dosing data. Clinical studies use IV bolus or continuous infusion. Subcutaneous is common in biohacking contexts. Short cycles only. |
Reported ranges are for research context only. Consult a qualified healthcare professional before using any peptide.
Convert Kisspeptin-10 research-range units
Need to convert mg to mcg, dose volume, or U-100 syringe units? The Kisspeptin-10 dose calculator is preloaded with these ranges, or use the general dose unit converter.
Research summary
Clinical studies show kisspeptin-10 acutely raises LH and testosterone in men. George et al. (JCEM 2011, Edinburgh) gave healthy men IV boluses of 0.01-3.0 mcg/kg: LH rose dose-dependently with maximal stimulation at 1 mcg/kg (4.1 to 12.4 IU/L at 30 min, n=6), and a 22.5-hour infusion raised testosterone from 16.6 to 24.0 nmol/L and increased LH pulse frequency. Jayasena et al. (Hum Reprod 2015, Imperial College London) compared the two kisspeptin isoforms head-to-head against GnRH in healthy men and found GnRH roughly 3-fold more potent than kisspeptin-10 for LH release, with only five men per dosing group. Kisspeptin is being investigated as a diagnostic test for pubertal disorders and in fertility protocols. Trials to date are small physiological studies, not efficacy trials.[1][2][3]
Evidence grading
Each claimed benefit is graded by the strength of available evidence. Grades reflect study quality, not effect size.
Strong = multiple RCTs · Moderate = limited trials or observational · Preliminary = animal or in vitro only · Insufficient = anecdotal or no published data
Side effects
Side effects vary by individual. This is not an exhaustive list. Report unusual symptoms to a healthcare professional.
Common stacks
Peptides commonly paired with Kisspeptin-10 for synergistic effects.
Legal status
Not FDA-approved. In clinical investigation at multiple academic centers. Available as a research peptide. Not scheduled.
Sourcing & access
Research compound
Kisspeptin-10 is classified as a research compound. Regulatory status varies by jurisdiction. Always verify current legal status and source from vendors providing third-party certificates of analysis (COA).
Frequently asked questions
Kisspeptin-10 is a 10-amino acid neuropeptide and the shortest bioactive fragment of kisspeptin. It is the master switch of the hypothalamic-pituitary-gonadal axis, triggering GnRH release which controls testosterone, estrogen, LH, and FSH production.
Kisspeptin-10 binds to KISS1R (GPR54) receptors on GnRH neurons in the hypothalamus, triggering GnRH release. This initiates the HPG axis cascade: GnRH stimulates LH and FSH from the pituitary, which stimulates testosterone or estrogen production in the gonads.
Published studies at Edinburgh and Imperial College London report kisspeptin-10 as well tolerated over short exposures. Reported side effects include injection site discomfort, hot flashes, abdominal discomfort, and headache. These trials enrolled only a handful of men each and ran for hours to a day, so they cannot establish safety for repeated or long-term use.
Acutely, yes. George et al. (JCEM 2011) infused kisspeptin-10 into healthy men for 22.5 hours and saw testosterone rise from 16.6 to 24.0 nmol/L alongside increased LH pulse frequency. That was four men in a physiological study, not a treatment trial, and no study has tested whether the effect persists with repeated dosing.